NewslettersHuman Immunology News FDA Misses Congressional Deadline to Update Clinical Trial Diversity Guidance By Noshin Noorjahan - February 20, 2024 0 The US FDA is several weeks late in issuing guidance on how and when drug and device companies must submit diversity action plans for clinical trial research. [Regulatory Affairs Professionals Society] Press Release